Dr Reddy’s Laboratories Ltd said it will before long send off the nonexclusive rendition of Merck’s antiviral COVID-19 pill, Molnupiravir,
The antiviral pill will be named as ‘Molflu’, and the organization will value it at ₹35 per container, an organization representative said today.
Indian medication controller Central Drugs Standard Control Organization (CDSCO) had supported the counter popular medication Molnupiravir for limited crisis use against Covid on December 28.
“Molnupiravir, an antiviral medication, will currently be fabricated in the country by 13 organizations for confined use under crisis for treatment of grown-up patients with Covid-19 and who have a high danger of movement of the sickness,”
